- Need Free Consultation?
WHO-GMP & cGMP Certified Pharmaceutical CDMO
Pioneering Manufacturing Science & Regulatory Integrity in Healthcare
Altora Lifesciences operates as an integrated pharmaceutical contract development and commercial manufacturing organization. Supplying high-volume PCD distribution networks, institutional hospital formularies, and export markets across 35+ countries with validated regulatory dossiers.
2.5B+
Annual Finished Units Capacity
Across 9 Dedicated Production Lines
99.8%
Right-First-Time Batch Release
Strict In-Process Quality Controls
35+
Global Export Territories
ACTD & eCTD Dossier Readiness
150+
Commercial Formulation Molecules
Essential Generics & Specialty Therapeutics
Guiding Philosophy
Engineered for Zero-Defect Manufacturing
Our operating model is founded on rigorous pharmacological science, uncompromising contamination containment, and transparent commercial partnerships.
01
Patient Safety as Non-Negotiable Core
Zero-Defect Quality Assurance
Every formulation batch is subjected to comprehensive validated testing protocols in accordance with WHO-GMP, cGMP, and Revised Schedule M standards. We maintain 100% optical inspection and continuous environmental monitoring.
02
Cross-Contamination Elimination
Segregation & Integrity
Physical and pressure-cascade containment separation for beta-lactams, cephalosporins, and general oral lines. Dedicated AHU systems with terminal HEPA filtration guarantee zero airborne cross-migration.
03
Rapid Pilot to Commercial Scale-up
Agile Technology Transfer
Our dedicated Tech Transfer and Analytical Method Validation (AMV) desk accelerates pilot batches to commercial release within 3 to 6 weeks, supported by stability charging and regulatory documentation.
04
Turnkey International Licensing
Global Regulatory Dossiers
From Certificate of Pharmaceutical Product (COPP) to ready CTD/ACTD modules and Zone IVb stability data, Altora empowers domestic PCD partners and global distributors to register products seamlessly.
World-Class Capabilities
Plant Infrastructure & Sterile Engineering
Designed in accordance with international cGMP and ISO guidelines, featuring complete segregation for sensitive antibiotics, continuous WFI loops, and automated packaging.
Cleanroom Engineering & HVAC
Modular cleanrooms designed with dynamic air pressure cascades, 20 to 60 air changes per hour, and dedicated terminal HEPA filtration units (0.3 micron, 99.997% efficiency).
- ✓Grade A laminar flow filling zones for sterile parenterals and ampoules
- ✓Continuous particle count monitoring in aseptic cores
- ✓Dedicated dehumidified zones maintaining RH < 20% for dry syrup antibiotics
High-Purity Water for Injection (WFI)
State-of-the-art multi-column distillation generation producing USP/EP grade Water for Injection and Purified Water with sanitary SS 316L orbital-welded piping.
- ✓Zero-dead-leg diaphragm sampling valves throughout the facility
- ✓Continuous online Total Organic Carbon (TOC) & conductivity monitoring
- ✓Daily microbiological bioburden and LAL bacterial endotoxin validation
High-Speed Automated Packaging Lines
Integrated blister packaging, rotary flame-sealing, induction bottle sealing, and automated cartoners equipped with online vision inspection and 2D DataMatrix tracking.
- ✓High-barrier Alu-Alu cold form foil and PVDC packaging suites
- ✓One-Point Cut (OPC) glass ampoules with hermetic flame sealing
- ✓Tamper-evident cartons with patient leaflets and anti-counterfeiting serialization
GLP-Accredited Analytical Testing Labs
Comprehensive wet chemical, instrumental, and microbiological testing labs equipped for active ingredient assay, related substance profiling, and microbial enumeration.
- ✓Shimadzu & Waters High-Performance Liquid Chromatographs (HPLC) and Gas Chromatographs (GC)
- ✓ICH Zone IVb (40°C ± 2°C / 75% RH ± 5% RH) stability walk-in chambers
- ✓Sterility testing isolators and Class 100 biological safety cabinets
Evolution of Excellence
Altora Lifesciences Development Milestones
A trajectory of calculated capacity investments, cleanroom modernization, and progressive formulation diversification.
Foundation
Legacy
Inception of Altora Lifesciences
Established with a founding commitment to elevate third-party pharmaceutical contract manufacturing in India through automated infrastructure and stringent cGMP adherence.
Phase I
Capacity Expansion
Solid Oral & Liquid Formulations Commissioning
Commercialized high-volume rotary tablet compression, high-speed capsule encapsulation, and multi-head oral liquid syrup filling lines exceeding 500 million units capacity.
Phase II
Sterile Processing
Sterile Parenterals & Ampoules Facility Expansion
Engineered Class 100 sterile suites featuring high-speed ultrasonic ampoule washing, 350°C continuous depyrogenation tunnels, and automated hermetic flame-sealing lines.
Phase III
Specialty Formulations
Softgel & Isolated Cephalosporin Powder Lines
Integrated rotary die soft gelatin encapsulation for lipid-soluble molecules and segregated dry powder injection suites under restricted access barriers (RABS).
Present
Global Scale
Global CDMO Benchmarking & 9 Formulation Verticals
Operating 9 specialized dosage lines, supplying domestic PCD networks, major hospital formularies, and export markets across 35+ countries with ready CTD dossiers.
Corporate Governance
Executive Leadership & Scientific Advisory
Led by pharmaceutical veterans with over two decades of experience in commercial pharmaceutical manufacturing, aseptic engineering, and international drug licensing.
E
Executive Management Desk
Managing Director & Strategic Operations
M.Pharm, MBA · 22+ Years in Pharma Manufacturing
Oversees Altora Lifesciences long-term corporate governance, capital engineering projects, and commercial client partnerships across India and international markets.
V
VP - Quality Assurance & Regulatory Affairs
Head of Corporate Quality Architecture
Ph.D. in Analytical Chemistry · Former National Regulatory Auditor
Leads our autonomous Quality Assurance and Quality Control departments, enforcing zero-defect compliance with WHO-GMP, Revised Schedule M, and global pharmacopeial monographs.
H
Head of Formulations R&D & Tech Transfer
Chief Technical Formulator
M.Tech Pharmaceutical Technology · 18+ Years CDMO Experience
Directs pre-formulation feasibility studies, analytical method development (AMD), pilot scale-up trials, and commercial validation campaigns for partner brands.
D
Director of Plant Engineering & Sterile Systems
Chief Engineering Officer
B.E. Mechanical & HVAC Systems Specialist
Maintains our mission-critical facilities, WFI loops, cleanroom pressure cascades, automated flame-sealing lines, and environmental sustainability systems.
Ready to Initiate a Manufacturing Partnership?
Discuss technical feasibility, request loan license procurement, or schedule an in-person facility inspection with our commercial development desk.